238 studies found for:    "Adenocarcinoma of lung"
Show Display Options
RSS Create an RSS feed from your search for:
"Adenocarcinoma of lung"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting NOV120101 (Poziotinib) for 1st Line Monotherapy in Patients With Lung Adenocarcinoma
Conditions: Adenocarcinoma of Lung Stage IIIB;   Adenocarcinoma of Lung Stage IV
Intervention: Drug: NOV120101 (Poziotinib)
2 Unknown  Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung Adenocarcinoma
Condition: Lung Adenocarcinoma
Intervention:
3 Recruiting Erlotinib Plus Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases
Conditions: Lung Adenocarcinoma;   Brain Metastases
Interventions: Drug: erlotinib;   Drug: pemetrexed;   Drug: cisplatin
4 Recruiting Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy
Condition: Lung Adenocarcinoma
Intervention: Other: CT, PET, copy number alteration
5 Recruiting Telomere Biology in Early Adenocarcinoma of the Lung
Conditions: Adenocarcinoma of the Lung;   Adenocarcinoma, Bronchiolo-Alveolar
Intervention:
6 Completed Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung
Conditions: Non-small-cell Lung Cancer;   Squamous Cell Carcinoma;   Adenocarcinoma of the Lung
Interventions: Drug: AXL1717;   Drug: Docetaxel
7 Unknown  The Use of CT Perfusion to Determine the Normalization Window Period in the Treatment of Advanced Primary Lung Adenocarcinoma With Endostar
Condition: Advanced Primary Lung Adenocarcinoma
Intervention: Drug: endostar
8 Not yet recruiting Prognostic Value of the Marker P63 in Adenocarcinoma of Lung, Breast, and Pancreas
Conditions: Lung Adenocarcinoma;   Breast Adenocarcinoma;   Pancreatic Ductal Adenocarcinoma
Intervention: Other: their will be no intervention in any of the groups, the study is retrospective
9 Not yet recruiting Comparison of cVATS Segmentectomy Versus Lobectomy for Lung Adenocarcinoma in Situ and With Microinvasion
Conditions: Non-small Cell Lung Cancer Stage I;   Lung Adenocarcinoma
Interventions: Procedure: patients undergo cVATS segmentectomy;   Procedure: Patients undergo cVATS lobectomy
10 Completed Cetuximab in Patients With Lung Adenocarcinoma Receiving Erlotinib That Have Developed "Acquired Resistance" to Erlotinib
Condition: Lung Adenocarcinoma
Intervention: Drug: erlotinib along with cetuximab
11 Not yet recruiting A Study Examining Maintenance Avastin Monotherapy in Patients With Advanced Lung Adenocarcinoma
Condition: Lung Adenocarcinoma
Intervention:
12 Completed Study of Vintafolide (MK-8109, EC145) in Participants With Progressive Adenocarcinoma of the Lung (MK-8109-008, EC-FV-03)
Condition: Adenocarcinoma of the Lung
Interventions: Drug: Vintafolide;   Drug: Etarfolatide
13 Completed A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
Condition: Adenocarcinoma of the Lung
Interventions: Biological: farletuzumab;   Other: Placebo;   Drug: Platinum Containing Doublet
14 Recruiting Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas
Condition: Stage IV Lung Adenocarcinoma
Interventions: Drug: Certolizumab;   Drug: cisplatin;   Drug: pemetrexed
15 Unknown  Expression of Optic Atrophy Type 1 (OPA1) Protein in Lung Adenocarcinoma
Condition: Lung Adenocarcinoma
Intervention:
16 Recruiting Study of the Safety and Activity of Lenvatinib (E7080) in Subjects With KIF5B-RET-Positive Adenocarcinoma of the Lung
Condition: KIF5B-RET-Positive Adenocarcinoma of the Lung
Intervention: Drug: Lenvatinib
17 Recruiting Comparative Study of Chemoradiation and Sequential Chemoradiation About Lung Adenocarcinoma Patients With Postoperative in pN2
Condition: Lung Adenocarcinoma Patients With Postoperative in pN2
Intervention: Radiation: intensity-modulated radiation
18 Recruiting A Randomized Phase II Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma.
Conditions: Carcinoma, Non-Small-Cell Lung;   Lung Adenocarcinoma
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Bevacizumab;   Drug: Metformin
19 Active, not recruiting Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer
Conditions: Adenocarcinoma of the Lung;   Non-small Cell Lung Cancer
Interventions: Drug: erlotinib hydrochloride;   Drug: Hsp90 inhibitor AUY922;   Other: laboratory biomarker analysis;   Procedure: needle biopsy;   Genetic: mutation analysis;   Other: pharmacological study
20 Completed Treatment of Lung Adenocarcinoma With Bronchioloalveolar Feature
Conditions: Pneumonic-type Adenocarcinoma (P-ADC);   Lung Adenocarcinoma With Bronchiolo-alveolar Feature
Intervention: Drug: Gefitinib

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years